£2.0M
Anthemis Exponential Ventures led the seed round with participation from APEX Ventures and Entrepreneur First.
Novoic
Novoic develops speech-based artificial intelligence algorithms for early neurological disease detection.
£2.0MTotal raised
Novoic is a digital biotechnology company developing speech-based artificial intelligence algorithms to detect and monitor neurological conditions. The firm focuses on creating software as a medical device for early diagnosis.
Categories
Founders
EF
Emil Fristed
co-founder and CEO
Emil is the co-founder and CEO of Novoic. He previously worked as an assistant research scientist in the King Group at the University of Oxford.
LinkedIn